UBC Medical Indonesia Tbk. vs Satyamitra Kemas Lestari Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Satyamitra Kemas Lestari Tbk. trades at Rp135 (market cap 475.11B, 11.2M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Satyamitra Kemas Lestari Tbk. is more actively traded (11.2M versus 3.48M). Which is the better fit depends on your goals.
| LABS | SMKL | |
|---|---|---|
Market Cap | 576.7B | 475.11B |
Volume | 3.48M | 11.2M |
Lot | 34.82K | 112K |
Turnover | 522.79M | 1.69B |
Average Price | 150.13 | 151.01 |
Value | 522.79M | 1.69B |
Indicative Equilibrium Price | 148 | 135 |
Indicative Equilibrium Volume | 350 | 50 |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Satyamitra Kemas Lestari Tbk (The Company) was established based on Deed of Establishment No. 12 dated July 26, 2001 which was made in the presence of Juniaty Tedjaputra, S.H., a notary in Tangerang.
Read more on SMKL →